Sign in

CIK 0001159036

  • Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880488686
Phone
+1 858-794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,144,286
in 6 filings, $22.1M under 10b5-1 plans

Net −$22,144,286. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-22 LaBarre Michael J. SVP, Chief Technical Officer Exercise or conversion · Restricted Stock Units −8,803 0
2021-02-22 Torley Helen President and CEO Exercise or conversion +39,354 556,671
2021-02-22 Torley Helen President and CEO Shares withheld for taxes −19,511 $48.69 $950K 537,160
2021-02-22 Torley Helen President and CEO Exercise or conversion · Restricted Stock Units −39,354 0
2021-02-15 Matsuda Masaru SVP, General Counsel Grant or award · Option to Purchase Common Stock +23,311 23,311
2021-02-15 Matsuda Masaru SVP, General Counsel Grant or award · Restricted Stock Units +13,544 13,544
2021-02-15 LaBarre Michael J. SVP, Chief Technical Officer Grant or award · Option to Purchase Common Stock +23,311 23,311
2021-02-15 LaBarre Michael J. SVP, Chief Technical Officer Grant or award · Restricted Stock Units +13,544 13,544
2021-02-15 Sun Elaine D SVP, Chief Financial Officer Grant or award · Option to Purchase Common Stock +25,642 25,642
2021-02-15 Sun Elaine D SVP, Chief Financial Officer Grant or award · Restricted Stock Units +14,898 14,898
2021-02-15 Torley Helen President and CEO Grant or award · Option to Purchase Common Stock +90,134 90,134
2021-02-15 Torley Helen President and CEO Grant or award · Restricted Stock Units +52,368 52,368
2021-02-14 LaBarre Michael J. SVP, Chief Technical Officer Exercise or conversion +5,771 138,957
2021-02-14 LaBarre Michael J. SVP, Chief Technical Officer Shares withheld for taxes −2,272 $49.84 $113K 136,685
2021-02-14 LaBarre Michael J. SVP, Chief Technical Officer Exercise or conversion · Restricted Stock Units −5,771 5,771
2021-02-14 Torley Helen President and CEO Exercise or conversion +28,729 531,560
2021-02-14 Torley Helen President and CEO Shares withheld for taxes −14,243 $49.84 $710K 517,317
2021-02-14 Torley Helen President and CEO Exercise or conversion · Restricted Stock Units −28,729 28,729
2021-02-12 Matsuda Masaru SVP, General Counsel Exercise or conversion +4,129 18,625
2021-02-12 Matsuda Masaru SVP, General Counsel Shares withheld for taxes −2,047 $49.84 $102K 16,578

Page 52 of 59 · 1,177 trades